Intrinsiqs

Is Novartis AG overvalued?

Novartis AG (NVS) looks fairly valued — trading about 4% above its fair value.

Fairly valued
Current price $159.90 Fair value $153.54
Price
$159.90
Fair value
$153.54
Current P/E
18.4
Normal P/E
17.7
Market cap
$305.10B
Dividend yield
3.1%
Return on equity
31.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NVS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 4 Jul 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.